The authors conducted a post hoc analysis of data from @ randomized studies that compared saxagliptin versus placebo as initial combination therapy with metformin for @ weeks ( N = @ ) and versus placebo as an add-on to insulin with and without metformin for @ weeks ( N = @ ) , and assessed noninferiority to glipizide as an add-on to metformin for @ weeks ( N = @ ) .